Category Specific RSS

Market Update

US shares rebound modestly, XJO to follow

The XJO is expected to open higher this morning following a rebound from key support in the U.S overnight. Their futures however have dipped into the red, which is likely dampening the enthusiasm of this morning’s open. Keep in mind that U.S futures during our sessions this week have been telling fibs, with overnight trading not really following what has been heralded. Indeed yesterday, they pointed to further falls and a break of support.

Yesterday our market stuck its head below the key support at 6,900 in a dramatic show of willingness to continue lower had the U.S failed at support last night. Our meek gains this morning further exemplify the bearish lamentation that underpins our market at present, which is unlikely to change until the U.S commits to further gains. Our market remains sceptical.

6,900 is the key support and bottom of the broad channel we have been trading in for almost a year. We have tested this level a few times in the past, with a strong rebound and rally following the stall. There are several good reasons to believe we should see the same thing this time around: October is often a positive month for markets that are preceded by a negative September; our market is at the bottom of the channel and oversold in both the short, medium and long-term; the U.S is at key support and their 200 day MA; sentiment around monetary policy has not shifted enough since the beginning of the recent falls to justify continued selling, especially considering where markets are at. All this combined offers a good platform for markets to rally, but be mindful we could see a fake-out to the downside before strength truly returns. This may translate to our market reaching 6,800.

Of course, we should wait for signals and trade what we see.

US Markets

US shares pushed higher overnight as prices rebounded somewhat from the recent selling. It came as bond yields reversed earlier gains, with the US 30-yr yield hitting 5 percent before retreating strongly. Mostly it just seems like a bit of reversion, with prices rebounded from strong selling over the past few weeks. US economic data was a bit mixed overnight, but it didn’t point to the economic slowdown that may be needed for interest rates to top out. Factory orders and S&P Global PMIs were stronger than expected, though a measure of job creation came in lower than expected. Investors will likely want to see weakening economic data from here before committing to a strong rebound. The next potential event that could trigger this is likely Friday night’s US unemployment report, though it sounds bad, markets will likely want to see unemployment start to rise a little.

Nine of the eleven sector groups of the SP500 rallied overnight, with only Energy stocks falling strongly. Strength was pretty broad-based, with Discretionary, Communications, Materials, and Technology stocks all faring well.

Technically, the SP500 is trading around the support at 4,250, and the 200-day moving average and longer-term uptrend line, which sat just a few points below this level. Overall the index is definitely in a downwards move, but its hard to say where it will find support. However, there are plenty of potential levels between 4,200 – 4,250, so it may have to close below 4,200 before another leg lower is triggered.

Want to learn how to trade?

The team at TradersCircle/Emerald Financial have released a free online stock market education course, click here to enrol and get started.

Karo Cornips

Joining the team at TradersCircle in 2011, Karo has extensive experience in both investing education and derivatives trading.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago